Analyst Confidence Soars as Addus HomeCare Receives Multiple Price Target Upgrades

Market analysts are expressing strong bullish sentiment toward Addus HomeCare, with ten separate firms now recommending the stock as a buy opportunity. The consensus view suggests substantial upside potential, with average price targets indicating more than 20 percent growth from current trading levels.

Several major financial institutions have recently updated their assessments of Addus HomeCare’s stock value:

• Stephens maintained its Overweight rating with a $140 target (September 3)
• RBC Capital Markets raised its target from $133 to $134 while keeping an Outperform rating (August 22)
• TD Cowen increased its target from $135 to $139, reiterating a Strong Buy recommendation (August 6)
• Barclays significantly adjusted its target upward from $83 to $109, despite maintaining... Read more...